PEG-Intron, a longer-acting form of Intron-A for treating hepatitis C

February 2001

Schering is now introducing PEG-Intron, a longer-acting form of Intron-A for treating hepatitis C.

PEG-Intron is the first "pegylated" interferon.

It's made by linking polyethylene glycol (PEG) to Intron-A (interferon alfa-2b). PEG slows the metabolism of the interferon and makes it longer-acting.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

laws to help reduce medication errors
Diabetes Starlix (nateglinide), a new oral tablet for type 2 diabetes
Diabetes The Health Care Financing Administration (HCFA) has FINALLY said how much and who will get paid for diabetes education
Dermatology Protopic, a new NON-STEROIDAL ointment for eczema
Women's Health Femara (letrozole) or Arimidex (anastrozole) for breast cancer
Women's Health the safety of misoprostol use during labor and delivery
Substance Use Disorder drugs of abuse
Infectious Diseases new immunization schedule for children
Infectious Diseases PEG-Intron, a longer-acting form of Intron-A for treating hepatitis C
Gastroenterology too many hospital patients get acid-suppressing drugs
Gastroenterology new chewable Lactobacillus tablet called Probiotica
Cardiology new IV anticoagulant, Angiomax (bivalirudin)
Migraine ACE inhibitor to PREVENT migraines
Migraine valproate to TREAT migraines
whether inhaled steroids are useful for treating COP
Diabetes statins reduce the risk of developing diabetes
Practice new drugs approved by the FDA in 2000

PEG-Intron, a longer-acting form of Intron-A for treating hepatitis C

Practical advice for a better career, with unlimited access to CE

Table of Contents